Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-26 @ 4:10 AM
Study NCT ID:
NCT05195827
Status:
WITHDRAWN
Last Update Posted:
2023-03-20
First Post:
2022-01-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effect of PRM-125 on Ambulatory Blood Pressure
Sponsor:
PRM Pharma, LLC
Organization:
Study Overview
Official Title:
Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults With Hypertension
Status:
WITHDRAWN
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults with Hypertension
Detailed Description:
Approximately 60 subjects with primary hypertension are treated for 8 weeks with PRM125 to determine if Ambulatory Blood Pressure is changed.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: